UCB SA Announces Dividend of $0.46 (OTCMKTS:UCBJY)

UCB SA (OTCMKTS:UCBJY) announced a dividend on Friday, April 19th, investing.com reports. Shareholders of record on Monday, April 29th will be given a dividend of 0.4574 per share on Wednesday, May 15th. This represents a yield of 0.71%. The ex-dividend date of this dividend is Friday, April 26th.

UCB Trading Down 0.7 %

UCB stock opened at $64.79 on Thursday. The business’s 50-day simple moving average is $59.07 and its two-hundred day simple moving average is $47.78. UCB has a fifty-two week low of $34.85 and a fifty-two week high of $65.55.

UCB Company Profile

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.